Leading in Cardiovascular
Tissue Engineering

We are a biotechnology company focussing on the development and manufacturing of biological medical devices. Our cell-free implants minimize the need for long-term medication, which helps to reduce possible negative side effects. This can significantly improve the quality of life, especially for younger patients.
More Than
0
Years in Business
Available in
0
Countries
More than
10000
Implants Worldwide

Technology

Auto Tissue Berlin uses a proprietary and patented glutaraldehyde-free process to decellularize and sterilize the biological tissue. Decellularized tissue has repeatedly proven to be superior to glutaraldehyde-treated tissue in terms of durability, especially in children.
Read more...

Contract Manufacturing

Auto Tissue Berlin also offers contract research and manufacturing services for all types of biological tissue, and supports engineering, design and prototyping of cardiovascular devices.

Read more...

Products

The Matrix Patch™ is a cell-free equine pericardial patch for vascular reconstruction and cardiac defect repair. It is primarily used in pediatric cardiac surgery and for valve repair in adults.

Read more...

Latest News

March 7, 2024

ProFIT Project ‘Decellularised Stented Heart Valve (DGH)’

Exciting news! Our latest project, ‘Decellularized Stented Heart Valve (DGH)’, funded by the Berlin Senate and the EU, aims to revolutionise cardiovascular care. By developing a decellularised stented surgical aortic valve, we offer an innovative alternative to glutaraldehyde-treated valves, promising improved hydrodynamics and reduced patient risks.

Read more  

December 11, 2023

New publication: 20-Year follow-up and comparison of valved conduits used for right ventricular outflow tract reconstruction.

Fadi Sabateen from the Department of Pediatric Cardiac Surgery, Children’s Heart Centre, National Institute of Cardiovascular Diseases, Bratislava, Slovakia published today a new report on the 20-Year follow-up and comparison of valved conduits used for right ventricular outflow tract reconstruction.

Read more  

November 28, 2023

New publication: Mid-term results following pulmonary artery patch augmentation in congenital heart disease

Maria von Stumm from the Department of Congenital and Pediatric Heart Surgery, German Heart Center Munich, School of Medicine, Technical University of Munich, Munich, Germany published today a new report on mid-term results following pulmonary artery patch augmentation in congenital heart disease. The results achieved with the Auto Tissue Berlin Matrix Patch equine are very positive.

Read more